To determine the effects of dietary prebiotics on growth performance and immune status of weanling pigs, 64 crossbred pigs (initial BW = 6.6 kg; d 20 to 22 post-farrowing) were selected and randomly allotted to 16 experimental pens with 4 dietary treatments (2 barrows and 2 gilts per pen, 4 pens per treatment). The treatments were maintained during Phase I (d 0 to 14 postweaning) and Phase II (d 14 to 28 postweaning). The control diet was a conventional nursery diet formulated with corn, soybean meal, dried whey, fish meal, bovine plasma, and supplements to meet or exceed the 2012 NRC requirements. The additional 3 diets were formulated to contain 0.1% chicory, 0.1% mannan oligosaccharides (MOS), and 0.02% chitosan, respectively. Pigs were given ad libitum access to feed and water in an environmentally-controlled room. From d 0 to 28 postweaning, feed disappearance and individual BW were measured weekly for determination of ADG, ADFI, and G:F. Blood samples were collected weekly for measurements of serum IgA concentrations. Data were analyzed as a completely randomized design using the MIXED procedure of SAS. Overall, dietary prebiotics did not affect (P > 0.10) BW (average 16.7 kg; d 28), ADG (361 g), or ADFI (513 g). However, from d 7 to 14, pigs fed MOS had lower (671 g/kg; P < 0.05) G:F compared to pigs fed control (830 g/kg), chicory (851 g/kg), and chitosan (871 g/kg) diets. For Phase I, G:F of pigs fed MOS tended to be lower (656 g/kg; P < 0.10) than pigs fed control (791 g/kg) and chitosan (783 g/ kg), but was not different from chicory (755 g/kg; P > 0.10). For Phase II, G:F of pigs fed control (673 g/kg), chicory (686 g/kg), MOS (695 g/kg), and chitosan (695 g/kg) were not different (P > 0.10). There were no time × treatment interactions (P > 0.10) affecting circulating IgA concentrations. Serum IgA increased (P < 0.05) over time from 0.148 to 0.438 mg/mL (d 0 to 28 postweaning), but was not affected by dietary prebiotic. In conclusion, with the exception of subtle decreases in feed efficiency, prebiotic supplementation had no effect on growth performance or serum IgA concentrations in weanling pigs. This study was performed to determine the effect of modified yeast cell wall extract (YCWE) (Mycosorb A+, Alltech, Lexington, KY) on growth and health of pigs fed diets naturally contaminated with aflatoxin B1 and fumonisin under the FDA regulatory level. One hundred twenty pigs (60 barrows and 60 gilts at 55.69 ± 6.29 kg BW) were randomly allotted to 4 treatments (2 × 2 factorial arrangement) with 10 pens (3 pigs per pen) per treatment, and fed the experimental diets for 5 wk period. Factors were mycotoxin (0 or 150 ug/kg aflatoxin and 19 mg/kg fumonisin) and YCWE (0 or 2 g/kg diet). All diets were formulated to meet or exceed the NRC nutrient requirements. Feed intake and body weight were measured weekly. At the end of 5 wk, 32 pigs representing a median BW of 8 pens per treatment were selected to take blood samples and euthanized to obtain intestinal tissues. Blood samples were obtained to measure the numbers of blood cells, and to separate serum for liver function test, tumor necrosis factor- (TNF-), immunoglobulin G (lgG), malondialdehyde (MDA), and 8-hydroxy-2'-deoxyguanosine (8-OHdG).
This study was performed to determine the effect of modified yeast cell wall extract (YCWE) (Mycosorb A+, Alltech, Lexington, KY) on growth and health of pigs fed diets naturally contaminated with aflatoxin B1 and fumonisin under the FDA regulatory level. One hundred twenty pigs (60 barrows and 60 gilts at 55.69 ± 6.29 kg BW) were randomly allotted to 4 treatments (2 × 2 factorial arrangement) with 10 pens (3 pigs per pen) per treatment, and fed the experimental diets for 5 wk period. Factors were mycotoxin (0 or 150 ug/kg aflatoxin and 19 mg/kg fumonisin) and YCWE (0 or 2 g/kg diet). All diets were formulated to meet or exceed the NRC nutrient requirements. Feed intake and body weight were measured weekly. At the end of 5 wk, 32 pigs representing a median BW of 8 pens per treatment were selected to take blood samples and euthanized to obtain intestinal tissues. Blood samples were obtained to measure the numbers of blood cells, and to separate serum for liver function test, tumor necrosis factor- (TNF-), immunoglobulin G (lgG), malondialdehyde (MDA), and 8-hydroxy-2'-deoxyguanosine (8-OHdG). Mucosa from duodenum and jejunum were obtained to evaluate morphology and to measure TNF-, MDA, and IgG. Data were analyzed using the Mixed procedure in SAS with pen as the experimental unit using treatments and sex as fixed effects and initial BW as a random effect. Mycotoxin decreased (P < 0.05) ADG (1.210 to 0.992 kg/d) at 1 wk, and tended to decreased (P = 0.099) BW (68.4 to 67.5 kg) at 2 wk, without affecting overall growth performance after 5 wk feeding. Mycotoxin decreased (P < 0.05) neutrophil counts (7.28 to 5.83 cell/mL) and serum cholesterol (86.7 to 77.1 mg/dL). The YCWE decreased (P < 0.05) serum 8-OHdG (1.48 to 0.60 ng/ mL), and tended to decrease (P = 0.051) crypt depth (285 to 261 µm) in duodenum. TNF-, MDA, and IgG in serum and intestinal mucosa were not affected by 2 treatment factors. There was no interaction between 2 treatment factors. Collectively, dietary mycotoxin under the FDA regulatory level had minor effects on growth performance and hematology, and supplemental YCWE reduced oxidative stress in pigs indicated by reduced serum 8-OHdG. A total of 480 pigs (PIC 327 × 1050; initially 48.7 kg) were used to determine the interactive effects of supplemental Cu, Zn, and ractopamine HCl on finishing pig growth, carcass characteristics, and antimicrobial susceptibility of enteric bacteria. Treatments were arranged in a 2 × 2 × 2 factorial with main effects of added copper (CuSO 4 ; 0 vs. 125 ppm Cu), added zinc (ZnO; 0 vs. 150 ppm Zn) and ractopamine HCl (0 vs. 10 ppm during the last 28 d before marketing; Paylean ® ; Elanco Animal Health, Greenfield, IN). All diets contained 11 ppm Cu and 73 ppm Zn from the trace mineral premix. Pens of pigs were balanced and blocked on initial BW then randomly allotted to 1 of the 4 mineral treatment diets. Twenty-eight d before marketing, pens within each block and mineral treatment were randomly assigned to receive either 0 or 10 ppm ractopamine in addition to the mineral treatment. Adding either Cu or Zn alone did not improve ADG or ADFI yet resulted in numerical improvements in overall G:F and caloric efficiencies but improvements were not additive (Cu × Zn, P = 0.057, 0.068 and 0.064 for G:F and caloric efficiency on a ME and NE basis, respectively). Ractopamine improved (P < 0.001) overall ADG, G:F, and caloric efficiency thereby increasing final BW by 3% with no change in ADFI. Ractopamine increased (P < 0.001) HCW, percent carcass yield, HCW G:F, loin depth, and percent fat-free lean and decreased (P = 0.014) backfat. An interaction existed whereby adding Zn or Cu alone to diets containing ractopamine numerically improved percent carcass yield and HCW G:F, but no improvement was observed when the Cu or Zn was added to the control diet or when Cu and Zn were fed in combination in the ractopamine diets (Cu × Zn × ractopamine, P = 0.011 and 0.018 for yield and HCW G:F, respectively). Fecal samples were collected on d 0 and at the conclusion of the finishing period (d 90) for bacterial isolation and antimicrobial susceptibility determinations according to minimal inhibitory concentration breakpoints. Escherichia coli and Enterococcus spp. isolates displayed varying levels of resistance to certain antibiotics before initiation of treatments on d 0. Resistance to most antibiotics decreased (P < 0.05) over time or was stable for those that had a low base-line percentage of resistance. Ractopamine and Zn did not adversely affect antimicrobial resistance but extended feeding of 125 ppm Cu throughout the finishing period appeared to antagonize any time-associated decrease in enterococcal resistance to tetracycline, tylosin, and quinupristin/dalfopristin. 
